TY - JOUR AU - Paget, S. PY - 1889 DA - 1889// TI - The distribution of secondary growths in cancer of the breast. JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(00)49915-0 DO - 10.1016/S0140-6736(00)49915-0 ID - Paget1889 ER - TY - JOUR AU - Guise, T. A. AU - Yin, J. J. AU - Taylor, S. D. AU - Kumagai, Y. AU - Dallas, M. AU - Boyce, B. F. AU - Yoneda, T. AU - Mundy, G. R. PY - 1996 DA - 1996// TI - Evidence for a causal role of parathyroid hormone-related protein in pathogenesis of human breast cancer-mediated osteolysis. JO - J Clin Invest VL - 98 UR - https://doi.org/10.1172/JCI118947 DO - 10.1172/JCI118947 ID - Guise1996 ER - TY - JOUR AU - Yin, J. J. AU - Selander, K. AU - Chirgwin, J. M. AU - Dallas, M. AU - Grubbs, B. G. AU - Wieser, R. AU - Massagué, J. AU - Mundy, G. R. AU - Guise, T. A. PY - 1999 DA - 1999// TI - TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. JO - J Clin Invest VL - 103 UR - https://doi.org/10.1172/JCI3523 DO - 10.1172/JCI3523 ID - Yin1999 ER - TY - JOUR AU - Shipman, C. M. AU - Rogers, M. J. AU - Apperley, J. F. AU - Russell, R. G. AU - Croucher, P. I. PY - 1997 DA - 1997// TI - Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumor activity. JO - Br J Haematol VL - 98 UR - https://doi.org/10.1046/j.1365-2141.1997.2713086.x DO - 10.1046/j.1365-2141.1997.2713086.x ID - Shipman1997 ER - TY - JOUR AU - Shipman, C. M. AU - Croucher, P. I. AU - Russell, R. G. R. AU - Helfrich, M. A. AU - Rogers, M. J. PY - 1998 DA - 1998// TI - The bisphosphonate incadronate (YM 175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. JO - Cancer Res VL - 58 ID - Shipman1998 ER - TY - JOUR AU - Aparicio, A. AU - Gardner, A. AU - Tu, Y. AU - Savage, A. AU - Berenson, J. AU - Lichtenstein, A. PY - 1998 DA - 1998// TI - In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates. JO - Leukemia VL - 12 UR - https://doi.org/10.1038/sj.leu.2400892 DO - 10.1038/sj.leu.2400892 ID - Aparicio1998 ER - TY - JOUR AU - Busch, M. AU - Rave-Frank, M. AU - Hille, A. AU - Duhmke, E. PY - 1998 DA - 1998// TI - Influence of clodronate on breast cancer cells in vitro. JO - Eur J Med Res VL - 3 ID - Busch1998 ER - TY - JOUR AU - Fromigue, D. AU - Siwek, B. AU - Body, J. J. PY - 1999 DA - 1999// TI - Bisphosphonates inhibit breast cancer cell proliferation. JO - Calcif Tissue Int VL - 64 ID - Fromigue1999 ER - TY - JOUR AU - Rogers, M. J. AU - Frith, J. C. AU - Luckman, S. P. AU - Coxon, F. P. AU - Benford, H. L. AU - Monkkonene, J. AU - Auriola, S. AU - Chilton, K. M. AU - Russell, R. G. PY - 1999 DA - 1999// TI - Molecular mechanism of action of bisphosphonates. JO - Bone VL - 24 UR - https://doi.org/10.1016/S8756-3282(99)00070-8 DO - 10.1016/S8756-3282(99)00070-8 ID - Rogers1999 ER - TY - JOUR AU - Fleisch, H. PY - 2002 DA - 2002// TI - Development of bisphosphonates. JO - Breast Cancer Res VL - 4 UR - https://doi.org/10.1186/bcr414 DO - 10.1186/bcr414 ID - Fleisch2002 ER - TY - JOUR AU - Dunford, J. E. AU - Thompson, K. AU - Coxon, F. P. AU - Luckman, S. P. AU - Hahn, F. M. AU - Poulter, C. D. AU - Ebetino, F. H. AU - Rogers, M. J. PY - 2001 DA - 2001// TI - Structure–activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. JO - J Pharmacol Exp Ther VL - 296 ID - Dunford2001 ER - TY - JOUR AU - Rogers, M. J. AU - Gordon, S. AU - Benford, H. L. AU - Coxon, F. P. AU - Luckman, S. P. AU - Monkkonen, J. AU - Frith, J. C. PY - 2000 DA - 2000// TI - Cellular and molecular mechanisms of action of bisphosphonates. JO - Cancer VL - 88 UR - https://doi.org/3.0.CO;2-L DO - 3.0.CO;2-L ID - Rogers2000 ER - TY - JOUR AU - Derenne, S. AU - Amiot, M. AU - Barille, S. AU - Bollette, M. AU - Robillard, N. AU - Berthaud, P. AU - Harousseau, J. L. AU - Bataille, R. PY - 1999 DA - 1999// TI - Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment. JO - J Bone Miner Res VL - 14 UR - https://doi.org/10.1359/jbmr.1999.14.12.2048 DO - 10.1359/jbmr.1999.14.12.2048 ID - Derenne1999 ER - TY - JOUR AU - van der Pluijm, G. AU - Vloedgraven, H. AU - van Beek, E. AU - van der Wee-Pals, L. AU - Löwik, C. AU - Papapoulos, S. PY - 1996 DA - 1996// TI - Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. JO - J Clin Invest VL - 98 UR - https://doi.org/10.1172/JCI118841 DO - 10.1172/JCI118841 ID - van der Pluijm1996 ER - TY - JOUR AU - Senaratne, S. G. AU - Colston, K. W. PY - 2002 DA - 2002// TI - Direct effects of bisphosphonates on breast cancer cells. JO - Breast Cancer Res VL - 4 UR - https://doi.org/10.1186/bcr412 DO - 10.1186/bcr412 ID - Senaratne2002 ER - TY - JOUR AU - Senaratne, S. G. AU - Pirianov, G. AU - Mansi, J. L. AU - Arnett, T. R. AU - Colston, K. W. PY - 2000 DA - 2000// TI - Bisphosphonates induce apoptosis in human breast cancer cell lines. JO - Br J Cancer VL - 82 UR - https://doi.org/10.1054/bjoc.1999.1131 DO - 10.1054/bjoc.1999.1131 ID - Senaratne2000 ER - TY - JOUR AU - Boissier, S. AU - Magnetto, S. AU - Frappart, L. AU - Cuzin, B. AU - Ebetino, F. H. AU - Delmas, P. D. AU - Clezardin, P. PY - 1997 DA - 1997// TI - Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrix. JO - Cancer Res VL - 57 ID - Boissier1997 ER - TY - JOUR AU - Selander, K. S. AU - Mönkkönen, J. AU - Karhukorpi, E. K. AU - Harkonen, P. AU - Han-nuniemi, R. AU - Vaanenen, H. K. PY - 1996 DA - 1996// TI - Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. JO - Mol Pharmacol VL - 50 ID - Selander1996 ER - TY - JOUR AU - Virtanen, S. S. AU - Väänänen, H. K. AU - Härkönen, P. L. AU - Lakkakorpi, P. T. PY - 2001 DA - 2001// TI - Effects of alendronate on adhesion and invasion of breast and prostate cancer cells. JO - Calcif Tissue Int VL - 66 ID - Virtanen2001 ER - TY - JOUR AU - Yoneda, T. AU - Sasaki, A. AU - Mundy, G. R. PY - 2001 DA - 2001// TI - Osteolytic bone disease in breast cancer. JO - Breast Cancer Res Treat VL - 32 UR - https://doi.org/10.1007/BF00666208 DO - 10.1007/BF00666208 ID - Yoneda2001 ER - TY - JOUR AU - Sasaki, A. AU - Boyce, B. F. AU - Wright, K. R. AU - Chapman, M. AU - Boyce, R. AU - Mundy, G. R. AU - Yoneda, T. PY - 1995 DA - 1995// TI - Bisphosphonate risedronate reduces metastastic human breast cancer burden in nude mice. JO - Cancer Res VL - 55 ID - Sasaki1995 ER - TY - JOUR AU - Sasaki, A. AU - Kitamura, K. AU - Alcalde, R. E. AU - Tanaka, T. AU - Suzuki, A. AU - Etoh, Y. AU - Matsumura, T. PY - 1998 DA - 1998// TI - Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice. JO - Int J Cancer VL - 77 UR - https://doi.org/3.0.CO;2-6 DO - 3.0.CO;2-6 ID - Sasaki1998 ER - TY - JOUR AU - Yoneda, T. AU - Michigami, T. AU - Yi, B. AU - Williams, P. J. AU - Niewolna, M. AU - Hiragu, T. PY - 2000 DA - 2000// TI - Actions of bisphosphonates on bone metastases in animal models of breast carcinoma. JO - Cancer Suppl VL - 88 UR - https://doi.org/3.0.CO;2-U DO - 3.0.CO;2-U ID - Yoneda2000 ER - TY - JOUR AU - Kostenuik, P. J. AU - Ori, F. W. AU - Suyama, K. AU - Singh, G. PY - 1993 DA - 1993// TI - Increased growth rate and tumor burden of spontaneously metastastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats. JO - Cancer Res VL - 53 ID - Kostenuik1993 ER - TY - JOUR AU - Hiraga, T. AU - Williams, P. J. AU - Mundy, G. R. AU - Yoneda, T. PY - 2001 DA - 2001// TI - The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. JO - Cancer Res VL - 61 ID - Hiraga2001 ER - TY - JOUR AU - Mundy, G. R. AU - Yoneda, T. AU - Hiraga, T. PY - 2001 DA - 2001// TI - Preclinical studies with zoledronic acid and other bisphosphonates: Impact on the bone microenviroment. JO - Semin Oncol VL - 28(suppl 6) UR - https://doi.org/10.1016/S0093-7754(01)90263-5 DO - 10.1016/S0093-7754(01)90263-5 ID - Mundy2001 ER - TY - JOUR AU - Hall, D. G. AU - Stoico, G. PY - 1994 DA - 1994// TI - Effect of the bisphosphonate Risedronate on bone metastases in rat mammary adenocarcinoma model system. JO - J Bone Miner Res VL - 9 UR - https://doi.org/10.1002/jbmr.5650090211 DO - 10.1002/jbmr.5650090211 ID - Hall1994 ER - TY - JOUR AU - Krempien, B. AU - Diel, I. J. AU - Jockle-Kretz, B. AU - Buchele, R. AU - Andre, L. PY - 1984 DA - 1984// TI - The Walker Carcinosarcoma 256 model of bone metastases, Influence of skeletal metabolism on the development of bone metastases. JO - Verh Dtsch Ges Pathol VL - 68 ID - Krempien1984 ER - TY - JOUR AU - Krempien, B. AU - Manegold, C. PY - 1993 DA - 1993// TI - Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate Cl2MBP. JO - Cancer VL - 72 UR - https://doi.org/3.0.CO;2-2 DO - 3.0.CO;2-2 ID - Krempien1993 ER - TY - JOUR AU - Krempien, B. AU - Wingen, F. AU - Eichmann, T. AU - Muller, M. AU - Schmahl, D. PY - 1998 DA - 1998// TI - Protective effects of a prophylactic treatment with bisphosphonate 3-amino-1-hydroxypropanel, 1 bisphonic acid on the development of tumor osteopathies in rat: experimental studies with the Walker Carcinosarcoma 256. JO - Oncology VL - 45 UR - https://doi.org/10.1159/000226528 DO - 10.1159/000226528 ID - Krempien1998 ER - TY - JOUR AU - Hortobagyi, G. N. AU - Theriault, R. L. AU - Porter, L. AU - Blayney, D. AU - Lipton, A. AU - Sinoff, C. AU - Wheeler, H. AU - Simeone, J. F. AU - Seaman, J. AU - Knight, R. D. PY - 1996 DA - 1996// TI - Efficacy of pamidronate in reducting skeletal complications in patients with breast cancer and lytic bone metastases. JO - N Engl J Med VL - 335 UR - https://doi.org/10.1056/NEJM199612123352401 DO - 10.1056/NEJM199612123352401 ID - Hortobagyi1996 ER - TY - JOUR AU - van Holten-Verzantvoort, A. T. M. AU - Kroon, H. M. AU - Bijvoet, O. L. M. AU - Cleton, F. J. AU - Beex, L. V. A. M. AU - Blijham, G. AU - Hermans, J. AU - Neijt, J. P. AU - Papapoulos, S. E. AU - Sleeboom, H. P. PY - 1993 DA - 1993// TI - Palliative pamidronate treatment in patients with bone metastases from breast cancer. JO - J Clin Oncol VL - 11 ID - van Holten-Verzantvoort1993 ER - TY - JOUR AU - Lipton, A. AU - Theriault, R. L. AU - Hortobagyi, G. N. AU - Simeone, J. AU - Knight, R. D. AU - Mellars, K. AU - Reitsma, D. J. AU - Heffernan, M. AU - Seaman, J. J. PY - 2000 DA - 2000// TI - Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases – Long term followup of two randomized, placebo-controlled trials. JO - Cancer VL - 88 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - Lipton2000 ER - TY - JOUR AU - Kurth, A. H. A. AU - Kim, S. -. Z. AU - Sedlmeyer, I. AU - Hovy, L. AU - Bauss, F. PY - 2000 DA - 2000// TI - Treatment with ibandronate preserves bone in experimental tumor-induced bone loss. JO - J Bone Joint Surg VL - 82-B UR - https://doi.org/10.1302/0301-620X.82B1.9483 DO - 10.1302/0301-620X.82B1.9483 ID - Kurth2000 ER - TY - JOUR AU - Green, J. R. PY - 2000 DA - 2000// TI - Anti-tumor potential of bisphosphonates. JO - Med Klin VL - 95 ID - Green2000 ER - TY - JOUR AU - Diel, I. J. AU - Solomayer, E. -. F. AU - Costa, S. D. AU - Gollan, C. AU - Goerner, R. AU - Wallwiener, D. AU - Kaufmann, M. AU - Bastert, G. PY - 1998 DA - 1998// TI - Reduction in new metastases in breast cancer with adjuvant clodronate treatment. JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199808063390601 DO - 10.1056/NEJM199808063390601 ID - Diel1998 ER - TY - JOUR AU - Saarto, T. AU - Blomqvist, C. AU - Virkkunen, P. AU - Elomaa, I. PY - 2001 DA - 2001// TI - Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial. JO - J Clin Oncol VL - 19 ID - Saarto2001 ER -